Your browser doesn't support javascript.
loading
Assessing and engineering the IscB-ωRNA system for programmed genome editing.
Yan, Hao; Tan, Xiaoqing; Zou, Siyuan; Sun, Yihong; Ke, Ailong; Tang, Weixin.
  • Yan H; Department of Chemistry, The University of Chicago, Chicago, IL, USA.
  • Tan X; Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
  • Zou S; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
  • Sun Y; Department of Chemistry, The University of Chicago, Chicago, IL, USA.
  • Ke A; Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
  • Tang W; Department of Chemistry, The University of Chicago, Chicago, IL, USA.
Nat Chem Biol ; 2024 Jul 08.
Article en En | MEDLINE | ID: mdl-38977787
ABSTRACT
OMEGA RNARNA)-guided endonuclease IscB, the evolutionary ancestor of Cas9, is an attractive system for in vivo genome editing because of its compact size and mechanistic resemblance to Cas9. However, wild-type IscB-ωRNA systems show limited activity in human cells. Here we report enhanced OgeuIscB, which, with eight amino acid substitutions, displayed a fourfold increase in in vitro DNA-binding affinity and a 30.4-fold improvement in insertion-deletion (indel) formation efficiency in human cells. Paired with structure-guided ωRNA engineering, the enhanced OgeuIscB-ωRNA systems efficiently edited the human genome across 26 target sites, attaining up to 87.3% indel and 62.2% base-editing frequencies. Both wild-type and engineered OgeuIscB-ωRNA showed moderate fidelity in editing the human genome, with off-target profiles revealing key determinants of target selection including an NARR target-adjacent motif (TAM) and the TAM-proximal 14 nucleotides in the R-loop. Collectively, our engineered OgeuIscB-ωRNA systems are programmable, potent and sufficiently specific for human genome editing.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article